Marshall Wace’s Spindletop Health Acquisition Corp. Class A Common Stock SHCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-853,199
Closed -$8.59M 3689
2022
Q3
$8.59M Buy
853,199
+122,155
+17% +$1.23M 0.02% 989
2022
Q2
$7.31M Buy
731,044
+118,211
+19% +$1.18M 0.02% 1088
2022
Q1
$6.16M Buy
612,833
+262,833
+75% +$2.61M 0.01% 1217
2021
Q4
$3.51M Buy
+350,000
New +$3.34M 0.01% 1647

Marshall Wace's SHCA Position: Q4 2022 in Review

Marshall Wace sold out of Spindletop Health Acquisition Corp. Class A Common Stock (SHCA) in Q4 2022, closing a stake of 853,199 shares — an estimated $8.59M sold.

Marshall Wace first reported a position in SHCA in Q4 2021 and held it in 4 quarters. The position peaked at $8.59M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHCA as of Q4 2022.

  • Marshall Wace reported no remaining Spindletop Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 853,199 Spindletop Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $8.59M.
  • Marshall Wace first reported a position in Spindletop Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Marshall Wace's Spindletop Health Acquisition Corp. Class A Common Stock position peaked at $8.59M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Spindletop Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.